Literature DB >> 10727717

Inhibition of 5-HT3 receptors by propofol: equilibrium and kinetic measurements.

M Barann1, J P Dilger, H Bönisch, M Göthert, A Dybek, B W Urban.   

Abstract

Patch-clamp/rapid solution exchange experiments as well as tracer ([14C]-guanidinium) influx measurements were applied to investigate effects of propofol on 5-HT3 receptor channels and compare the results with those obtained with pentobarbital. Currents induced by 30 microM 5-HT were recorded in outside-out patches from N1E-115 cells. Application of propofol 45 s before and during 5-HT application inhibited peak-currents and integrated current responses in a concentration-dependent manner (IC50 values=14.5 and 10.5 microM; Hill coefficients -1.5 and -1.3, respectively). The inhibitory effect of propofol in the current measurements was similar to the propofol-induced inhibition in tracer influx experiments in whole N1E-115 cells (Barann et al., 1993. Naunyn-Schmiedeberg's Archives of Pharmacology 347, 125-132). Pentobarbital-induced inhibition of 5-HT3 receptors in both patch-clamp (Barann et al., 1997. Neuropharmacology 36, 655-664) and tracer influx measurements indicated a lower potency and lower slope (IC50 values=130 and 55 microM; Hill coefficients -0.8 and -0.7, respectively) compared to propofol. Propofol, in contrast to pentobarbital, showed nearly the full potency when applied to the patches exclusively 45 s before 5-HT. Propofol was least effective when administered exclusively during 5-HT. The onset of inhibition of 5-HT-induced peak currents by propofol had a time constant of 220 ms, similar to the kinetics of 5-HT-induced desensitization.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10727717     DOI: 10.1016/s0028-3908(99)00205-1

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  9 in total

1.  Inhibition of human 5-HT(3A) and 5-HT(3AB) receptors by etomidate, propofol and pentobarbital.

Authors:  Dirk Rüsch; Hans A Braun; Hinnerk Wulf; Anika Schuster; Douglas E Raines
Journal:  Eur J Pharmacol       Date:  2007-07-13       Impact factor: 4.432

2.  Interactions of metoclopramide and ergotamine with human 5-HT(3A) receptors and human 5-HT reuptake carriers.

Authors:  Jan Walkembach; Michael Brüss; Bernd W Urban; Martin Barann
Journal:  Br J Pharmacol       Date:  2005-10       Impact factor: 8.739

Review 3.  [What do we know about anesthetic mechanisms?: hypnosis, unresponsiveness to surgical incision and amnesia].

Authors:  V-S Eckle; C Hucklenbruch; S M Todorovic
Journal:  Anaesthesist       Date:  2009-11       Impact factor: 1.041

4.  Molecular interactions between general anesthetics and the 5HT2B receptor.

Authors:  Felipe Matsunaga; Lu Gao; Xi-Ping Huang; Jeffery G Saven; Bryan L Roth; Renyu Liu
Journal:  J Biomol Struct Dyn       Date:  2013-12-23

5.  Influence of sodium substitutes on 5-HT-mediated effects at mouse 5-HT3 receptors.

Authors:  M Barann; K Schmidt; M Göthert; B W Urban; H Bönisch
Journal:  Br J Pharmacol       Date:  2004-05-17       Impact factor: 8.739

6.  Identification of Glycyrrhiza as the rikkunshito constituent with the highest antagonistic potential on heterologously expressed 5-HT3A receptors due to the action of flavonoids.

Authors:  Robin Herbrechter; Paul M Ziemba; Katrin M Hoffmann; Hanns Hatt; Markus Werner; Günter Gisselmann
Journal:  Front Pharmacol       Date:  2015-07-03       Impact factor: 5.810

Review 7.  Natural Negative Allosteric Modulators of 5-HT₃ Receptors.

Authors:  Lina T Al Kury; Mohamed Mahgoub; Frank Christopher Howarth; Murat Oz
Journal:  Molecules       Date:  2018-12-03       Impact factor: 4.411

8.  Antimalarial drugs inhibit human 5-HT(3) and GABA(A) but not GABA(C) receptors.

Authors:  A J Thompson; S C R Lummis
Journal:  Br J Pharmacol       Date:  2008-03-03       Impact factor: 8.739

9.  Noncompetitive Inhibition of 5-HT3 Receptors by Citral, Linalool, and Eucalyptol Revealed by Nonlinear Mixed-Effects Modeling.

Authors:  Gavin E Jarvis; Roseli Barbosa; Andrew J Thompson
Journal:  J Pharmacol Exp Ther       Date:  2015-12-15       Impact factor: 4.030

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.